BG31073A3 - Метод за получаване на 1,5-заместени-2-пиролидони - Google Patents

Метод за получаване на 1,5-заместени-2-пиролидони

Info

Publication number
BG31073A3
BG31073A3 BG037109A BG3710977A BG31073A3 BG 31073 A3 BG31073 A3 BG 31073A3 BG 037109 A BG037109 A BG 037109A BG 3710977 A BG3710977 A BG 3710977A BG 31073 A3 BG31073 A3 BG 31073A3
Authority
BG
Bulgaria
Prior art keywords
pyrrolidones
substituted
preparation
disubstituted
proven
Prior art date
Application number
BG037109A
Other languages
Bulgarian (bg)
English (en)
Inventor
Albin Nelson
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG31073A3 publication Critical patent/BG31073A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG037109A 1976-08-06 1977-08-05 Метод за получаване на 1,5-заместени-2-пиролидони BG31073A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
BG31073A3 true BG31073A3 (bg) 1981-10-15

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
BG037109A BG31073A3 (bg) 1976-08-06 1977-08-05 Метод за получаване на 1,5-заместени-2-пиролидони

Country Status (31)

Country Link
JP (2) JPS5321159A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR217080A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT362887B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU508007B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE857506A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG31073A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1077948A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH624934A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS221269B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD143768A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2735904A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK352077A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES461388A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI70009C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2369260A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB1556569A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR68688B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU180273B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE45505B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL52615A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU77936A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7708637A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO772752L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ184806A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH17398A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL112931B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT66891B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE423813B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (3) SU703016A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU192577A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA774704B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
EP1132086B1 (en) 2000-01-31 2006-05-31 Pfizer Products Inc. Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
EP1339678B1 (en) * 2000-11-27 2007-09-26 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
EP1417975B1 (en) * 2001-07-23 2011-03-02 Ono Pharmaceutical Co., Ltd. Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
CA2478653A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1586564B1 (en) * 2003-01-21 2012-11-28 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
SE423813B (sv) 1982-06-07
FI70009B (fi) 1986-01-31
IE45505L (en) 1978-02-06
AR217080A1 (es) 1980-02-29
ATA579477A (de) 1980-11-15
GB1556570A (en) 1979-11-28
DD143768A5 (de) 1980-09-10
PT66891A (en) 1977-09-01
BE857506A (fr) 1978-02-06
DK352077A (da) 1978-02-07
DE2735904A1 (de) 1978-02-09
FR2369260B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-02-12
HU180273B (en) 1983-02-28
ES471349A1 (es) 1979-09-16
SU703016A3 (ru) 1979-12-05
JPS5531147B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-08-15
CS221269B2 (en) 1983-04-29
JPS585196B2 (ja) 1983-01-29
FI772376A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-02-07
AU2751577A (en) 1979-02-08
YU192577A (en) 1983-04-30
AU508007B2 (en) 1980-03-06
SE7708642L (sv) 1978-02-07
PL200124A1 (pl) 1978-05-22
FR2369260A1 (fr) 1978-05-26
NZ184806A (en) 1980-04-28
GB1556569A (en) 1979-11-28
CA1077948A (en) 1980-05-20
JPS5321159A (en) 1978-02-27
PL112931B1 (en) 1980-11-29
SU818480A3 (ru) 1981-03-30
IE45505B1 (en) 1982-09-08
ZA774704B (en) 1978-06-28
NO772752L (no) 1978-02-07
FI70009C (fi) 1986-09-12
ES461388A1 (es) 1978-12-01
AT362887B (de) 1981-06-25
IL52615A0 (en) 1977-10-31
PH17398A (en) 1984-08-08
IL52615A (en) 1981-09-13
DD136135A5 (de) 1979-06-20
SU850000A3 (ru) 1981-07-23
CH624934A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-08-31
NL7708637A (nl) 1978-02-08
PT66891B (en) 1979-01-26
LU77936A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-04-27
GR68688B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-02-01
JPS5555161A (en) 1980-04-22

Similar Documents

Publication Publication Date Title
BG31497A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортонизамиди
BG30019A3 (bg) Метод за получаване на тризаместени 1-фенил-2,3,4,5-тетрахидро-1н- 3-бензазепини
BG28065A4 (en) Method of obtaining of 2-phenyl-3-aroylbenzothiophenes
BG38164A3 (bg) Метод за получаване на n- заместени-4-пипериданамини
BG31499A3 (bg) Метод за получаване на 1-винилтриазолови производни
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG38333A3 (bg) Метод за получаване на заместени фенилкарбоксиоксими
BG28847A3 (bg) Метод за получаване на хидантоинови производни
BG29722A3 (bg) Метод за получаване на 2,5-дисубституирани пиримидин-4-они
BG31377A3 (bg) Метод за получаване на фенилетиламини
BG28068A3 (bg) Метод за получаване на -3- хлорцефалоспорини
BG28849A3 (bg) Метод за получаване на гамапирони
BG28072A4 (bg) Метод за получаване на 1 n заместени канамицинови производни
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG34036A3 (bg) Метод за получаване на пропаргил -2- фениламино- имидазолини-(2) и техните присъединителни с киселина соли
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG30475A3 (bg) Метод за получаване на депостероидни естери
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG33283A3 (bg) Метод за получаване на пиридазинилхидразони
BG35032A3 (bg) Метод за получаване на 1, 1, 2- трифенилпропенови производни
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG31229A3 (bg) Метод за получаване на n-(5-тетразолил)-1-оксо-1н-6-алкоксипиримидо(1,2-а)- хинолин-2-карбоксамиди